Engimmune Therapeutics, a biotech company developing novel T-cell receptor (TCR)-based therapeutics, has appointed Lars Nieba to the CEO position, replacing co-founder Søren Mouritsen, who is stepping down in a planned…
Engimmune Therapeutics, a biotech company developing novel T-cell receptor (TCR)-based therapeutics, has appointed Lars Nieba to the CEO position, replacing co-founder Søren Mouritsen, who is stepping down in a planned…
…
…